MC1641A1 - Oxazolidines - Google Patents
OxazolidinesInfo
- Publication number
- MC1641A1 MC1641A1 MC841735A MC1735A MC1641A1 MC 1641 A1 MC1641 A1 MC 1641A1 MC 841735 A MC841735 A MC 841735A MC 1735 A MC1735 A MC 1735A MC 1641 A1 MC1641 A1 MC 1641A1
- Authority
- MC
- Monaco
- Prior art keywords
- group
- phenyl
- methyl
- lower alkyl
- rev
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH6070/83A CH655931A5 (en) | 1983-11-10 | 1983-11-10 | Oxazolidines |
| CH449984 | 1984-09-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MC1641A1 true MC1641A1 (fr) | 1986-01-09 |
Family
ID=25695620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MC841735A MC1641A1 (fr) | 1983-11-10 | 1984-11-06 | Oxazolidines |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US4743604A (de) |
| AT (1) | AT387771B (de) |
| AU (1) | AU576531B2 (de) |
| BE (1) | BE900983A (de) |
| CA (1) | CA1249992A (de) |
| DE (1) | DE3438411A1 (de) |
| DK (1) | DK520584A (de) |
| ES (1) | ES8606863A1 (de) |
| FI (1) | FI844152A7 (de) |
| FR (1) | FR2554814B1 (de) |
| GB (1) | GB2149405B (de) |
| HU (1) | HU193465B (de) |
| IL (1) | IL73427A (de) |
| IT (1) | IT1177033B (de) |
| LU (1) | LU85631A1 (de) |
| MC (1) | MC1641A1 (de) |
| NL (1) | NL8403308A (de) |
| NO (1) | NO844501L (de) |
| NZ (1) | NZ210105A (de) |
| PH (1) | PH22462A (de) |
| PT (1) | PT79485B (de) |
| SE (1) | SE463099B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988009661A1 (en) * | 1987-06-10 | 1988-12-15 | Pfizer Inc. | Oxazolidin-2-one derivatives as hypoglycemic agents |
| FI892341L (fi) * | 1988-06-10 | 1989-12-11 | Hoffmann La Roche | Propanolaminderivat. |
| US5321036A (en) * | 1993-02-10 | 1994-06-14 | Bristol-Myers Squibb Company | Thiazole and oxazole-based β3 adrenergic receptor agonists |
| US5563171A (en) * | 1993-11-05 | 1996-10-08 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists |
| US5578638A (en) * | 1993-11-05 | 1996-11-26 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists |
| SK111195A3 (en) * | 1994-09-13 | 1997-06-04 | Sandoz Technology Ltd | Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same |
| US7510849B2 (en) * | 2004-01-29 | 2009-03-31 | Glucolight Corporation | OCT based method for diagnosis and therapy |
| US7254429B2 (en) | 2004-08-11 | 2007-08-07 | Glucolight Corporation | Method and apparatus for monitoring glucose levels in a biological tissue |
| US8036727B2 (en) | 2004-08-11 | 2011-10-11 | Glt Acquisition Corp. | Methods for noninvasively measuring analyte levels in a subject |
| EP1874178A4 (de) | 2005-04-13 | 2009-12-09 | Glucolight Corp | Verfahren zur datenreduzierung und kalibrierung eines blutzuckermonitors auf oct-basis |
| WO2009111542A2 (en) | 2008-03-04 | 2009-09-11 | Glucolight Corporation | Methods and systems for analyte level estimation in optical coherence tomography |
| WO2014108449A1 (en) | 2013-01-08 | 2014-07-17 | Atrogi Ab | A screening method, a kit, a method of treatment and a compound for use in a method of treatment |
| GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201903832D0 (en) | 2019-03-20 | 2019-05-01 | Atrogi Ab | New compounds and methods |
| GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA979912A (en) * | 1970-06-22 | 1975-12-16 | Frederic P. Hauck | Tetrahydronaphthyloxyaminopropanols and related compounds |
| GB1301134A (en) * | 1970-07-18 | 1972-12-29 | Pfizer Ltd | SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES |
-
1984
- 1984-10-11 CA CA000465149A patent/CA1249992A/en not_active Expired
- 1984-10-19 DE DE19843438411 patent/DE3438411A1/de not_active Withdrawn
- 1984-10-22 FI FI844152A patent/FI844152A7/fi not_active Application Discontinuation
- 1984-10-25 IT IT23307/84A patent/IT1177033B/it active
- 1984-10-31 NL NL8403308A patent/NL8403308A/nl not_active Application Discontinuation
- 1984-11-01 US US06/667,186 patent/US4743604A/en not_active Expired - Fee Related
- 1984-11-01 DK DK520584A patent/DK520584A/da not_active Application Discontinuation
- 1984-11-05 IL IL73427A patent/IL73427A/xx unknown
- 1984-11-05 NZ NZ210105A patent/NZ210105A/xx unknown
- 1984-11-06 BE BE0/213953A patent/BE900983A/fr not_active IP Right Cessation
- 1984-11-06 MC MC841735A patent/MC1641A1/fr unknown
- 1984-11-07 LU LU85631A patent/LU85631A1/de unknown
- 1984-11-08 FR FR8417009A patent/FR2554814B1/fr not_active Expired
- 1984-11-08 ES ES537487A patent/ES8606863A1/es not_active Expired
- 1984-11-09 GB GB08428335A patent/GB2149405B/en not_active Expired
- 1984-11-09 HU HU844174A patent/HU193465B/hu unknown
- 1984-11-09 AT AT0355384A patent/AT387771B/de not_active IP Right Cessation
- 1984-11-09 PT PT79485A patent/PT79485B/pt unknown
- 1984-11-09 NO NO844501A patent/NO844501L/no unknown
- 1984-11-09 AU AU35275/84A patent/AU576531B2/en not_active Ceased
- 1984-11-09 PH PH31427A patent/PH22462A/en unknown
- 1984-11-09 SE SE8405632A patent/SE463099B/sv not_active IP Right Cessation
-
1988
- 1988-02-05 US US07/152,522 patent/US4871755A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2007220868B2 (en) | Compounds for the treatment of metabolic disorders | |
| US7973052B2 (en) | Compounds for the treatment of metabolic disorders | |
| MC1536A1 (fr) | Nouvelles phenethanolamines | |
| FR2554814A1 (fr) | Oxazolidines, procede pour leur preparation et leurs utilisations therapeutiques, notamment dans le traitement de l'obesite et du diabete | |
| MC1831A1 (fr) | Derives de pyridine-ethalolamine | |
| CA2637375A1 (en) | Compounds for the treatment of metabolic disorders | |
| CA2637884A1 (en) | Compounds for the treatment of metabolic disorders | |
| MC1625A1 (fr) | Procede de preparation de phenoxypropanolamines | |
| LU81300A1 (fr) | Derives d'hydantoine,procede pour leur preparation et application de ces composes comme medicaments | |
| EP1546111A2 (de) | 2-thiohydantoin-verbindungen und deren verwendung zur behandlung von diabetis | |
| JP4697973B2 (ja) | 代謝障害の処置のための化合物 | |
| NZ569729A (en) | Compounds for the treatment of metabolic disorders | |
| EP0094595B1 (de) | Neue Aziridin- und Phenäthanolaminderivate | |
| MC1744A1 (fr) | Derives de phenylethanolamines | |
| AU2007208125B2 (en) | Compounds for the treatment of metabolic disorders | |
| MC2042A1 (fr) | Derives de propanolamine | |
| FR2845385A1 (fr) | Composes derives de la 2-thiohydantoine et leur utilisation en therapeutique | |
| EP0518769B1 (de) | Benzoesäureethanolaminesterderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
| FR2507180A1 (fr) | Nouvelles phenylalkylamines, leur preparation et leur application comme medicaments | |
| MC2104A1 (fr) | Bis-phenethanolamines | |
| FR2460931A1 (fr) | Medicaments a base de derives n-acyles du tryptophane | |
| FR2861072A1 (fr) | Derives de cyclopropylmethanones, leur preparation et leur utilisation en therapeutique | |
| MC1030A1 (fr) | Nouvelles amines et leurs procédés de préparation | |
| MX2008009594A (en) | Compounds for the treatment of metabolic disorders | |
| JPS60115568A (ja) | オキサゾリジン類 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| YP | Annual fee paid |